Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis-Reference-Cited by-同舟云学术

Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis

Published:2018-07-01 Issue:7 Volume:75 Page:827
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Wijburg Martijn T.¹²,Kleerekooper Iris¹²,Lissenberg-Witte Birgit I.³,de Vos Marlieke²,Warnke Clemens⁴⁵,Uitdehaag Bernard M. J.¹,Barkhof Frederik²⁶,Killestein Joep¹,Wattjes Mike P.²⁷

Affiliation:

1. Department of Neurology, Neuroscience Amsterdam, VUmc Multiple Sclerosis Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands

2. Department of Radiology and Nuclear Medicine, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands

3. Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands

4. Department of Neurology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

5. Department of Neurology, Medical Faculty, University of Köln, Köln, Germany

6. Institutes of Neurology and Healthcare Engineering, University College London, London, United Kingdom

7. Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Hannover, Germany

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Reference32 articles.

1. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.;Clifford;Lancet Neurol,2010

2. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.;Tan;Lancet Neurol,2010

3. Natalizumab: bench to bedside and beyond.;Rudick;JAMA Neurol,2013

4. PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.;Berger;Neurology,2013

5. Outcome and survival of asymptomatic PML in natalizumab-treated MS patients.;Dong-Si;Ann Clin Transl Neurol,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focal haemorrhage as atypical feature on MRI in progressive multifocal leukoencephalopathy;Neurology Asia;2024-06

2. Biomarkers for progressive multifocal leukoencephalopathy: emerging data for use of JC virus DNA copy number in clinical trials;The Lancet Neurology;2024-05

3. Surrogate endpoints for progressive multifocal leukoencephalopathy;The Lancet Neurology;2024-05

4. An atypical case of progressive multifocal leukoencephalopathy in a patient with high grade B-cell lymphoma causing diagnostic delay;JRSM Open;2023-10

5. Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations;Multiple Sclerosis and Related Disorders;2023-09